Over the course of a decade, out-of-pocket costs for multiple sclerosis drugs rose more than sevenfold for Medicare Part D
Read more
Home »
New tech for multiple sclerosis diagnosis and treatment: Patent-pending tool creates 3D images of brain lesions
Researchers at the Center for BrainHealth®, part of The University of Texas at Dallas, in collaboration with a team from
Read more
When drug treatment for social anxiety is insufficient
A Japanese study group clarified that cognitive therapy maintained its effects more than a year after the end of therapy
Read more
Fooling nerve cells into acting normal: Discovery could inform future studies related to spinal cord injuries, multiple sclerosis and epilepsy
Nerve cells, or neurons — specifically the “workhorse cells” involved in walking, breathing and chewing — can adjust to changes
Read more
Are most patients with fibromyalgia misdiagnosed?
Recent studies have suggested that most people who have been diagnosed with fibromyalgia by physicians may not actually have the
Read more
Botulinum toxin shows promise in trials to reduce post-operative atrial fibrillation (POAF) in cardiac surgery patients
Postoperative atrial fibrillation (POAF) is a common complication, affecting one quarter to one half of all patients following cardiac surgery.
Read more
Environmental associations with genes may yield opportunities for precision medicine
A new approach to genetic analysis finds associations between environmental factors and pharmacogenes — genes associated with a person’s response
Read more
Immune cells destroy healthy brain connections, diminish cognitive function in obese mice: Obesity may drive microglia into a synapse-eating frenzy that leads to cognitive impairment
Obesity leads to cognitive impairment by activating microglial cells, which consume otherwise functional synapses in the hippocampus, according to a
Read more
Multiple sclerosis drug slows brain shrinkage, study finds: Trial offers hope for disease with limited treatment options
Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better
Read more
Risk factors for fast-spreading facial gangrene
Noma, a rare disease found predominantly in underserved areas, causes progressive destruction, or gangrene, of the tissues of the face
Read more